These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17363337)

  • 1. Anxiolytic therapy with alprazolam increases muscle sympathetic activity in patients with panic disorders.
    Béchir M; Schwegler K; Chenevard R; Binggeli C; Caduff C; Büchi S; Buddeberg C; Lüscher TF; Noll G
    Auton Neurosci; 2007 Jul; 134(1-2):69-73. PubMed ID: 17363337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients.
    Pols H; Verburg K; Hauzer R; Meijer J; Griez E
    Biol Psychiatry; 1996 Nov; 40(9):913-7. PubMed ID: 8896779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    J Clin Psychopharmacol; 2006 Oct; 26(5):519-23. PubMed ID: 16974197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive style, alprazolam plasma levels, and treatment response in panic disorder.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    Depress Anxiety; 2008; 25(8):E18-26. PubMed ID: 17960759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diazepam versus alprazolam for the treatment of panic disorder.
    Noyes R; Burrows GD; Reich JH; Judd FK; Garvey MJ; Norman TR; Cook BL; Marriott P
    J Clin Psychiatry; 1996 Aug; 57(8):349-55. PubMed ID: 8752017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of alprazolam sublingual tablets in the treatment of the acute phase of panic disorders.
    Márquez M; Arenoso H; Caruso N
    Actas Esp Psiquiatr; 2011; 39(2):88-94. PubMed ID: 21404147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The speed of onset of action of alprazolam-XR compared to alprazolam-CT in panic disorder.
    Sheehan DV; Sheehan KH; Raj BA
    Psychopharmacol Bull; 2007; 40(2):63-81. PubMed ID: 17514187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinuation of alprazolam after long-term treatment of panic-related disorders.
    DuPont RL; Swinson RP; Ballenger JC; Burrows GD; Noyes R; Rubin RT; Rifkin A; Pecknold JC
    J Clin Psychopharmacol; 1992 Oct; 12(5):352-4. PubMed ID: 1479053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does blockade of the renin angiotensin system affect sympathetic and blood pressure responses to amlodipine in young hypertensive patients?
    Ruzicka M; Coletta E; Leenen FH
    Am J Hypertens; 2007 Nov; 20(11):1202-8. PubMed ID: 17954368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of hydrocortisone on sympathetic and hemodynamic responses to sympathoexcitatory manoeuvres in men.
    Heindl S; Vahlkamp K; Weitz G; Fehm HL; Dodt C
    Steroids; 2006 Mar; 71(3):206-13. PubMed ID: 16388832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The increase in sympathetic nerve activity after glucose ingestion is reduced in type I diabetes.
    Fagius J; Berne C
    Clin Sci (Lond); 2000 May; 98(5):627-32. PubMed ID: 10781396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzodiazepine sensitivity in panic disorder: effects of chronic alprazolam treatment.
    Cowley DS; Roy-Byrne PP; Radant A; Ritchie JC; Greenblatt DJ; Nemeroff CB; Hommer DW
    Neuropsychopharmacology; 1995 Apr; 12(2):147-57. PubMed ID: 7779243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy studies of alprazolam in panic disorder.
    Spiegel DA
    Psychopharmacol Bull; 1998; 34(2):191-5. PubMed ID: 9640999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agrypnia Excitata: a microneurographic study of muscle sympathetic nerve activity.
    Donadio V; Montagna P; Pennisi M; Rinaldi R; Di Stasi V; Avoni P; Bugiardini E; Giannoccaro MP; Cortelli P; Plazzi G; Baruzzi A; Liguori R
    Clin Neurophysiol; 2009 Jun; 120(6):1139-42. PubMed ID: 19442577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a novel environment on resting heart rate in panic disorder.
    Larsen DK; Asmundson GJ; Stein MB
    Depress Anxiety; 1998; 8(1):24-8. PubMed ID: 9750976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral, psycho-physiological and salivary cortisol modifications after short-term alprazolam treatment in patients with recent myocardial infarction.
    Pruneti C; Giusti M; Boem A; Luisi M
    Ital Heart J; 2002 Jan; 3(1):53-9. PubMed ID: 11899591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac sympathetic nerve biology and brain monoamine turnover in panic disorder.
    Esler M; Alvarenga M; Lambert G; Kaye D; Hastings J; Jennings G; Morris M; Schwarz R; Richards J
    Ann N Y Acad Sci; 2004 Jun; 1018():505-14. PubMed ID: 15240408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ambulatory monitoring of panic patients during regular activity: a preliminary report.
    Bystritsky A; Craske M; Maidenberg E; Vapnik T; Shapiro D
    Biol Psychiatry; 1995 Nov; 38(10):684-9. PubMed ID: 8555380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growing placebo response rate: the problem in recent therapeutic trials?
    Uhlenhuth EH; Matuzas W; Warner TD; Thompson PM
    Psychopharmacol Bull; 1997; 33(1):31-9. PubMed ID: 9133749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xanax XR for panic disorder.
    Med Lett Drugs Ther; 2003 May; 45(1157):43-4. PubMed ID: 12766702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.